[1] |
WU Lili, LIANG Zhi, HUANG Siyong, WANG Yan.
Effect of augmented renal clearance (ARC) on the pharmacokinetics, efficacy, and safety of vancomycin in patients with infective endocarditis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1139-1145.
|
[2] |
LIN Liangmo, FU Xiangjun, ZHONG Lili, WANG Hefang, WU Qiongshi, XIAO Jian.
Establishment of population pharmacokinetics model of vancomycin in patients with Neutropenia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(9): 1014-1022.
|
[3] |
FU Xiangjun, HUANG Li, GUO Li, LIN Liangmo.
Application of AUC/MIC as the therapeutic drug monitoring target of vancomycin in patients with severe infections of multi drug resistant gram positive bacteria
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(7): 775-781.
|
[4] |
GUO Xianzhong, LIN Rongfang, LIN Weiwei.
Development of software for individualizing dosage regimens of vancomycin based on population pharmacokinetics models
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(1): 30-39.
|
[5] |
LIN Zhong, XIE Qunli, DAI Shuping, CHEN Jing, LIN Feiyang, ZHU Yanwu, YU Guoliang, ZHANG Yuanhuai, CUI Ke.
Population pharmacokinetics of Linezolid in Chinese adult infection patients#br#
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 992-999.
|
[6] |
.
Research progress of linezolid-induced lactic acidosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(12): 1408-1413.
|
[7] |
ZHU Min, ZHANG Cuifeng, GUO Yiyun, ZHU Ziming.
Population pharmacokinetics of vancomycin in elderly infectious patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(2): 158-163.
|
[8] |
CHEN Yaoyao,SHI Daohua,LIU Guanghua,NIU Peiguang,LIU Baichen.
Effects of OCT2 and MDR1 gene polymorphisms on vancomycin concentration and clinical efficacy in infants
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(2): 154-158.
|
[9] |
DING Zhirong, CAI Xiaozhen, ZENG Haiwen, LIN Tianlai.
Population pharmacokinetics of vancomycin in post-operative neurosurgical patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(11): 1252-1257.
|
[10] |
ZHONG Ling, SHAO Hua, CHEN Yan, HU Linlin, YU Feng.
Advance in linezolid-induced thrombocytopenia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(10): 1196-1200.
|
[11] |
XU Jia, HUANG Qi, YANG Zhiling .
Evaluation of clinical rationality of linezolid in our hospital in 2016
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(1): 110-115.
|
[12] |
YU Huajun, HUANG Kai, ZHANG Zhan, GUO Qiaofeng, ZHANG Xiaowen, ZHANG Chun.
Efficacy and safety of vancomycin calcium sulfate combined with ultrashort wave in the treatment of traumatic osteomyelitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(5): 556-559.
|
[13] |
LI Chun-xing, FU Qiang, ZHU Zhu.
The tissue penetration and pharmacodynamics of linezolid in the infected tissues
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(3): 349-355.
|
[14] |
SUN Xiao-xiao, SHAO Hua, WANG You-qun.
Research progress of vancomycin nephrotoxicity
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(5): 597-600.
|
[15] |
JIN Yan-jie, ZHANG Jing, LU Ke-peng, LIU Qian, LIN Li-min, SONG Hong-tao.
Linezolid pharmacokinetics/pharmacodynamics and the development of dosage regimen design optimization
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(12): 1429-1434.
|